| Literature DB >> 35221607 |
Tigist Bacha1, Netsanet Tsegaye2, Wagari Tuli3.
Abstract
BACKGROUND: A few studies are available from Africa on the use of mechanical ventilation (MV) in the pediatric intensive care unit (PICU). Knowledge of the outcome of patients on MV is critical for better use of resources. We aimed to assess the characteristics and outcomes of mechanically ventilated pediatric patients in Tikur Anbessa Specialized Referral Hospital, Addis Ababa, Ethiopia.Entities:
Keywords: Ethiopia; Mechanical ventilation; Mortality; PIM II; Pediatric; intensive care
Mesh:
Year: 2021 PMID: 35221607 PMCID: PMC8843144 DOI: 10.4314/ejhs.v31i5.2
Source DB: PubMed Journal: Ethiop J Health Sci ISSN: 1029-1857
Clinical characteristics of the study population
| Variable | Frequency | Percentage | |
| Age | < 1 | 86 | 39.1 |
| 1–5 | 74 | 33.6 | |
| 6–12 | 60 | 27.3 | |
| Sex | Male | 140 | 63.6 |
| Female | 80 | 36.4 | |
| Length of stay in days | 1–3 days | 93 | 42.3 |
| 4–7days | 63 | 28.6 | |
| >8days | 64 | 29.1 | |
| PIM 2 score | Range (1–91) |
Etiology of admission of the study population
| Variable (n, %) | Frequency | Percentage | |
| Status epilepticus | 12 | 5 | |
| Neurology (41,18.7) | Brain abscess | 6 | 2.7 |
| Traumatic brain injury | 6 | 2.7 | |
| Meningitis | 7 | 3.2 | |
| Stroke | 4 | 1.8 | |
| Brain tumor | 3 | 1.4 | |
| Intra cranial hemorrhage | 2 | 0.9 | |
| Spinal cord injury | 1 | 0.5 | |
| Pneumonia | 15 | 6.8 | |
| Respiratory (46, 20.9) | Tuberculosis | 8 | 3.6 |
| FBA | 6 | 2.7 | |
| Apnea | 4 | 1.8 | |
| Aspiration pneumonia | 4 | 1.8 | |
| Lung contusion | 2 | 0.9 | |
| PCP | 2 | 0.9 | |
| HAAD | 1 | 0.5 | |
| HAP | 1 | 0.5 | |
| PTE | 1 | 0.5 | |
| Pulmonary edema | 1 | 0.5 | |
| Severe croup | 1 | 0.5 | |
| Post cardiac arrest | 14 | 6.4 | |
| Cardiac (29, 13.2%) | Congenital heart disease | 10 | 4.6 |
| Congestive heart failure | 3 | 1.4 | |
| SVT | 2 | 0.9 | |
| Sepsis (34, 15.5%) | 34 | 15.5 | |
| Renal (10, 4.5%) | Acute renal failure | 6 | 2.7 |
| Chronic renal failure | 4 | 1.8 | |
| Neuromascular (19, 8.6%) | Guillain Barrie syndrome | 19 | 8.6 |
| Superior mediastinal mass | 5 | 2.3 | |
| Malignancy (8, 3.6%) | Anterior mediastinal mass | 2 | 0.9 |
| Tumor lysis syndrome | 1 | 0.5 | |
| Other (33, 15%) | Post-operation | 28 | 12.7 |
| Poisoning | 2 | 0.9 | |
| Diabetic ketoacidosis | 1 | 0.5 | |
| Uremic encephalopathy | 2 | 0.9 |
FBA: foreign body aspiration PTE: Pulmonary thromboembolism, HAP: Hospital-acquired pneumonia, HAAD: Hyperactive airway disease, PCP: Pneumocystis carinii pneumonia. SVT: Supraventricular tachycardia
Outcome of mechanically ventilated pediatric patients in TASH PICU, (n=220) 2018
| Variable | Frequency | Percent | |
| Outcome | Survived | 90 | 39.9 |
| died | 130 | 59.1 | |
| Cause of | Sepsis | 59 | 26.8 |
| ARDS | 30 | 13.6 | |
| Brain death | 17 | 7.7 | |
| Intractable heart failure | 12 | 5.5 | |
| Other | 13 | 5.9 |
Renal failure, Surgical site bleeding, Tension pneumothorax, Blocked ETT, Intracranial hemorrhage
Logistic regression analysis of associated factors with mortality in mechanically ventilated pediatric patients in TASH pediatrics ICU (n=220) 2018
| Variable | Categories | Final Outcome | COR (95 % CI) | AOR (95% CI) | |
|
| |||||
| Survived | Died | ||||
| Age | < 1 year | 31 | 55 | 1.27 (0.64, 2.49) | |
| 1–5 year | 34 | 40 | 0.84 (0.42, 1.67) | ||
| 6–12 year | 25 | 35 | 1 | ||
| Sex | Female | 32 | 48 | 0.94(0.54, 1.64) | |
| Male | 58 | 82 | 1 | ||
| Type of cases | Medical | 48 | 112 | 5.44(2.933, 10.73) | 0.127(0.37,0.41) |
| Surgical | 42 | 18 | 1 | ||
| Admission | Neurology | 18 | 23 | 0.61(0.248, 1.49) | |
| Respiratory | 18 | 28 | 0.61(0.26, 1.41) | ||
| Cardiac | 11 | 18 | 0.45(0.18, 1.14) | ||
| Sepsis | 6 | 28 | 0.20(0.07, 0.58) | ||
| Neuromuscular | 15 | 4 | 3.42(0.97, 11.96) | ||
| Malignancy | 2 | 6 | 0.30(0.055, 1.67) | ||
| Renal | 2 | 10 | 0.20(0.07, 0.58) | ||
| Other | 23 | 10 | 1 | ||
| Indication for | Respiratory | 3 | 15 | 25(2.10, 29.28) | |
| Cardiovascular | 27 | 34 | 6.29(0.69, 7.14) | 7.149(1.30,39.48) | |
| Neurology | 55 | 80 | 7.27(0.83, 63.97) | ||
| Other (post op) | 5 | 1 | 1 | ||
| Length of stay | 1–3 days | 26 | 67 | 0.2 (0.11, 0.43) | 0.19(0.07,0.57) |
| 4–7 | 23 | 40 | 0.32(0.16, 0.67) | 0.26(0.09,0.77) | |
| > 8 | 41 | 23 | 1 | ||
| Comorbidities | SAM | 6 | 6 | 1.0(0.167, 5.98) | |
| Malignancy | 14 | 23 | 0.609(0.131, 2.83) | ||
| HIV | 1 | 3 | 0.33(0.02, 4.74) | ||
| CHD | 10 | 17 | 0.58(0.12, 2.81) | ||
| Renal | 1 | 3 | 0.33(0.23, 4.7) | ||
| Other | 4 | 4 | 1 | ||
| Modes MV | SIMV/VCV | 7 | 12 | 2.9(0.59, 14.06) | |
| AC/PCV | 2 | 8 | 4.3(0.51, 36.9) | ||
| AC/VCV | 1 | 6 | 0.24(0.2421, 0.05) | ||
| BIPAP/CPAP | 6 | 2 | 1 | ||
| CPR before | Yes | 12 | 27 | 1 | |
| No | 78 | 103 | 1.7(0.81,3.57) | ||
| Complication | Yes | 33 | 26 | 0.44(0.24, 0.8) | |
| No | 57 | 103 | 1 | ||
| MODS | Yes | 29 | 97 | 6.18 (3.4,11.18) | 0.181 (0.08,0.41) |
| No | 61 | 33 | 1 | ||
| PIM II Score | 0–9 | 54 | 50 | 0.417 (0.24, 0.72) | 4.35(1.7, 11) |
| 9–91 | 36 | 80 | 1 | ||
Mean and SD) (20, 23.9), MIN/MAX (1–91)
P value < 0.2 for COR
P value <0.05 for AOR